Bilateral optic neuritis induced by Adalimumab: A follow-up with visual evoked potentials

Abstract

Get full access to this article

View all access options for this article.

References

Kunchok

Aksamit

Davis

, et al. Association between tumor necrosis factor inhibitor exposure and inflammatory central nervous system events. JAMA Neurol 2020; 77: 937–946. doi: 10.1001/jamaneurol.2020.1162. PMID: 32421186; PMCID: PMC7235930.

Kaltsonoudis

Zikou

Voulgari

, et al. Neurological adverse events in patients receiving anti-TNF therapy : a prospective imaging and electrophysiological study. Arthritis Res Ther 2014; 16: R125.

Uchio

Yashita

Hao

, et al. Intravenous immunoglobulin in the treatment of Adalimumab-associated optic neuritis. Intern Med 2022; 61: 429–432. doi: 10.2169/internalmedicine.7599-21. Epub 2021 Aug 6. PMID: 34373376; PMCID: PMC8866781.

Pihl-Jensen

Schmidt

Frederiksen

. Multifocal visual evoked potentials in optic neuritis and multiple sclerosis: a review. Clin Neurophysiol 2017; 128: 1234–1245. doi: 10.1016/j.clinph.2017.03.047. Epub 2017 Apr 11. PMID: 28531809.

Dahanayake

Dassanayake

Pathirage

, et al. The effect of optic neuritis treatment trial (ONTT) combined corticosteroid regimen on pattern reversal visual evoked potentials: a prospective follow-up study. BMC Ophthalmol 2021; 21: 324. doi: 10.1186/s12886-02102086-z. PMID: 34488685; PMCID: PMC8422770.